Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR
2018-003597-26Phase 3Unknown
- Sponsor
- Allergan
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Allergan. Primary endpoint: Safety and ocular assessments. Status: unknown.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2018-003597-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003597-26.